Login

Progression to Insulin Therapy in Patients With Type 2 Diabetes - Dr. Peter Kokkinos, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Progression to Insulin Therapy in Patients With Type 2 Diabetes

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"Asian Credit as a Strategy to Manage Market Volatilities: Expert Insights from Aidan Yao, Senior Emerging Asia Economist at AXA Investment Managers"
00:00:00
4d pharma reveals 'phenomenal results' from early stage cancer trial - Duncan Peyton, CEO, 4D Pharma
00:10:00
Filo Mining: Advancing the Filo del Sol Project in South America
00:10:00
"Jennifer Tejada, CEO of PagerDuty, leads a company providing software to alert and mitigate glitches in data centers for businesses."|Jennifer Tejada is the Chairperson and CEO of PagerDuty
00:10:00
Maximizing Investment Potential: George Njunge - Senior Portfolio Manager at Britam Group
00:10:00
Institutions who provide the FUEL for our FOCUS on helping disruptive founders|Maggie Vo,Managing General Partner and Chief Investment Officer,Fuel Venture Capital
00:10:00
Discussion on the Post-Pandemic Business Landscape with Nordic Capital's COO | Klas Tikkanen , COO, Nordic Capital.
00:10:00
Expectations for Canada's Throne Speech: Health, Jobs, and Fiscal Prudence Amidst Economic Challenges| Nancy Southern , CEO, Atco Ltd.
00:10:00
Brickworks Ltd MD Discusses Full Year Results, Property Trust, and Dividend Policy with Tom Piotrowski | Lindsay Partridge - CEO of brickworks ltd
00:10:00
Schroder Investment Manager Shares Top Stock Picks | Eamonn Rothwell - CEO of Irish Continental Group
00:10:00
AI in Investing: Unlocking Alpha Through Future-Focused Sectors | Mark Bova, Co-Founders , Lenity Financial, Inc.
00:10:00
Jim Nesci on Blue Foundry Bank's Expansion and Competitive Edge | James D. Nesci, CEO, Blue Foundry Bank.

© 2017 - Neuhu+